Tizanidine is not approved for headaches, but clinical evidence supports its off-label use for both chronic migraines and chronic tension-type headaches. It works differently from typical pain relievers, targeting muscle tension and pain signaling in the central nervous system rather than blocking inflammation. Several doctors prescribe it as a preventive option when standard headache treatments fall short.
How Tizanidine Works for Headaches
Tizanidine was designed as a muscle relaxant. It activates receptors in the brain and spinal cord that dial down nerve signaling, reducing muscle tightness and spasm. Its only FDA-approved use is managing spasticity from conditions like multiple sclerosis and spinal cord injuries.
For headaches, the mechanism is slightly different. Tizanidine inhibits the release of norepinephrine, a stress-related chemical messenger, at both the spinal cord and brain level. This produces pain-relieving effects that are separate from the opioid system, meaning it reduces pain without working like a narcotic. By calming overactive nerve pathways and relaxing the muscle tension that often accompanies chronic headaches, it can lower both headache frequency and intensity over time.
Evidence for Chronic Daily Headaches
The strongest evidence comes from a double-blind, placebo-controlled trial published in the journal Headache that studied tizanidine as a daily preventive for chronic headaches. Compared to placebo, tizanidine significantly reduced total headache days per week, severe headache days, average headache intensity, peak headache intensity, and how long each headache lasted. The overall headache burden, measured as a combined index of frequency and severity, improved significantly more in the tizanidine group than in the placebo group.
During the final four weeks of treatment, patients on tizanidine saw about a 30% reduction in total headache days compared to 22% for placebo. While that gap didn’t quite reach statistical significance on its own, the broader pattern across all headache measures was consistently in tizanidine’s favor. Notably, the benefits were similar whether patients had chronic migraine or tension-type headaches, suggesting the drug works across headache types rather than favoring one.
Evidence for Tension-Type Headaches
A separate placebo-controlled crossover study focused specifically on chronic tension-type headaches in 37 women with headache histories ranging from seven months to 30 years. Each participant took both tizanidine and placebo for six-week periods, with a two-week break in between. Tizanidine outperformed placebo on every measure: pain severity on visual scales, number of headache-free days, and the amount of additional pain medication patients needed. Interestingly, neither depression scores nor the level of electrical activity in neck muscles predicted who would respond, suggesting the benefit isn’t simply about relaxing tight muscles or improving mood.
What to Expect From Side Effects
Tizanidine’s side effects are predictable and dose-related. In clinical studies, the most common were dizziness or lightheadedness (affecting roughly half of patients), drowsiness (about 48%), fatigue or weakness (43%), dry mouth (39%), stomach upset (30%), and sleep difficulties (22%). Most of these are mild and tend to lessen as your body adjusts, but drowsiness in particular can be significant, especially at higher doses. Many people find it helpful to take the medication at bedtime, which turns the sedation into a benefit rather than a nuisance.
Tizanidine also lowers blood pressure. For most people this effect is subtle, but it can cause lightheadedness when standing up quickly, especially early in treatment. Starting at a low dose and increasing gradually helps minimize this.
Dangerous Drug Interactions
Tizanidine is broken down in the liver by a specific enzyme pathway. Certain medications block that pathway, causing tizanidine levels to spike dangerously. The two most concerning are ciprofloxacin (a common antibiotic) and fluvoxamine (an antidepressant). When taken together with tizanidine, these drugs dramatically increase the risk of severe drops in blood pressure. An analysis of FDA adverse event reports found the combination with ciprofloxacin carried a 28-fold higher signal for dangerous hypotension, and fluvoxamine nearly 37-fold. Both are considered contraindicated with tizanidine. Other drugs that inhibit the same liver pathway, including some asthma medications, also carry risk. Your prescriber should review your full medication list before starting tizanidine.
Why You Should Never Stop It Abruptly
If you’ve been taking tizanidine regularly, stopping suddenly can trigger a withdrawal syndrome. Because the drug suppresses norepinephrine release, abrupt cessation causes a rebound surge of stress hormones. This can produce dangerously high blood pressure, rapid heart rate, increased muscle tightness, anxiety, and even fever. In one documented emergency case, a patient who stopped abruptly developed a blood pressure of 200/150 and a heart rate of 160 beats per minute.
The risk is highest in people taking larger doses, but it applies to anyone who has been on the medication for more than a short period. The standard approach is to taper gradually, typically reducing by about 2 mg per day, rather than stopping all at once. If withdrawal symptoms do occur, the treatment involves restarting tizanidine at a lower dose and then tapering more slowly.
Where Tizanidine Fits in Headache Treatment
Tizanidine is not a first-line headache treatment. It’s typically considered when conventional preventive medications haven’t worked well enough, when side effects from other options are intolerable, or when headaches co-exist with significant neck or shoulder muscle tension. It’s used as a daily preventive, not a rescue medication you take when a headache starts. Because it’s prescribed off-label for headaches, insurance coverage can vary, and not every provider will be familiar with its use for this purpose.
For people with chronic daily headaches or chronic tension-type headaches who haven’t found relief elsewhere, the clinical evidence shows meaningful reductions in headache frequency, intensity, and duration. The trade-off is navigating side effects like drowsiness and dry mouth, staying alert to drug interactions, and committing to a gradual taper if you ever decide to stop.